Page last updated: 2024-10-25

clioquinol and Osteogenic Sarcoma

clioquinol has been researched along with Osteogenic Sarcoma in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Balsa, LM1
Quispe, P1
Baran, EJ1
Lavecchia, MJ1
León, IE1

Other Studies

1 other study available for clioquinol and Osteogenic Sarcoma

ArticleYear
    Metallomics : integrated biometal science, 2020, 12-23, Volume: 12, Issue:12

    Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Clioquinol; Focal Adhesion Kinase 1; Humans

2020